Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections?

M S Amstey1, R S Gibbs

  • 1University of Rochester School of Medicine and Dentistry, New York.

Obstetrics and Gynecology
|December 1, 1994
PubMed

Insights

Penicillin G is preferred over ampicillin for preventing early neonatal group B streptococcal disease due to its pharmacokinetics and narrow spectrum. This ensures effective treatment and minimizes the risk of antibiotic resistance.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Infectious Diseases

Background:

  • Group B Streptococcus (GBS) is a significant cause of early neonatal disease.
  • Antibiotic prophylaxis is crucial for preventing GBS transmission during childbirth.
  • Penicillin G and ampicillin are commonly considered antibiotics for GBS prophylaxis.

Purpose of the Study:

  • To compare the efficacy of penicillin G and ampicillin for preventing early neonatal GBS disease.
  • To evaluate the pharmacokinetic profiles and spectrum of action of both antibiotics in the context of GBS prophylaxis.

Main Methods:

  • Review of existing literature on penicillin G and ampicillin pharmacokinetics.
  • Analysis of the spectrum of antimicrobial activity against Group B Streptococcus.
  • Assessment of placental transfer and fetal/neonatal tissue concentrations.

Main Results:

  • Penicillin G demonstrates favorable pharmacokinetics, including good placental transfer and adequate fetal and neonatal tissue levels.
  • Group B Streptococcus exhibits a narrower range of sensitivities to penicillin G compared to ampicillin.
  • Ampicillin's broader spectrum may increase the potential for selecting more resistant organisms.

Conclusions:

  • Penicillin G is favored over ampicillin for early neonatal GBS disease prophylaxis based on its pharmacokinetic advantages and narrower spectrum of action.
  • The use of penicillin G may reduce the risk of selecting for antibiotic-resistant GBS strains.
  • Optimal antibiotic selection is critical for effective GBS prevention in newborns.

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...